Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Omeprazole.

G Cheung1

  • 1Department of Pharmacy Services, Hartford Hospital.

Connecticut Medicine
|July 1, 1990
PubMed
Summary
This summary is machine-generated.

Omeprazole, the first acid-pump inhibitor, offers a novel treatment for gastrointestinal disorders like GERD. It is well-tolerated with mild side effects, making it a valuable therapeutic option.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Can a generic fracture fixation assessment tool be used to assess quality of distal radius fracture fixation, and predict fixation failure?

Annals of the Royal College of Surgeons of England·2026
Same author

Estimating the Prevalence of Dementia in New Zealand Using Capture-Recapture Analysis on Routinely Collected Health Data.

International journal of geriatric psychiatry·2024
Same author

Isolated volar dislocation of the distal radioulnar joint: a case series and systematic review.

Annals of the Royal College of Surgeons of England·2022
Same author

Legalisation of e-scooters in the UK: the injury rate and pattern is similar to those of bicycles in an inner city metropolitan area.

Public health·2022
Same author

Letter to the Editor: Healthy for Life: An Innovative and Collaborative Approach to COVID 19 Lockdown in New Zealand.

The Journal of frailty & aging·2020
Same author

Nonlinear plasma wavelength scalings in a laser wakefield accelerator.

Physical review. E·2020
Same journal

Incidence of Hepatitis C Virus and Other Bloodborne Virus Infections Among Nonurban Residents of Fairfield and New Haven Counties, Connecticut Who Inject Drugs.

Connecticut medicine·2021
Same journal

Remarks from the Annual Meeting.

Connecticut medicine·2018
Same journal

Address of the Outgoing President: Evolution.

Connecticut medicine·2018
Same journal

Address of the New President: One Society.

Connecticut medicine·2018
Same journal

Post Integration Trauma Syndrome (PITS).

Connecticut medicine·2018
Same journal

New Federal Drug Administration Fluoroquinolone Warning and a Practical Approach to Managing Patients.

Connecticut medicine·2018
See all related articles

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Gastroesophageal reflux disease (GERD) and hypersecretory conditions require effective treatments.
  • Acid-pump inhibitors represent a novel class of drugs for managing these disorders.

Purpose of the Study:

  • To introduce omeprazole as the first acid-pump inhibitor.
  • To highlight its unique mechanism of action and therapeutic applications.

Main Methods:

  • Review of omeprazole's pharmacological profile.
  • Analysis of clinical data regarding its efficacy and tolerability.

Main Results:

  • Omeprazole demonstrates a unique mechanism of action.
  • It is effective in treating GERD, reflux esophagitis, and hypersecretory conditions.
  • Adverse effects are generally mild and transient, indicating good tolerability.

    • Conclusions:

    • Omeprazole is a significant advancement in managing specific gastrointestinal disorders.
    • Its efficacy and favorable safety profile establish it as an important therapeutic agent.